Verma Saguna, Ziegler Katja, Ananthula Praveen, Co Juliene K G, Frisque Richard J, Yanagihara Richard, Nerurkar Vivek R
Retrovirology Research Laboratory, Department of Tropical Medicine and Medical Microbiology, John A. Burns School of Medicine, University of Hawaii at Manoa, Honolulu, 96822, USA.
Virology. 2006 Feb 20;345(2):457-67. doi: 10.1016/j.virol.2005.10.012. Epub 2005 Nov 17.
Human polyomavirus JC (JCV) infects 80% of the population worldwide. Primary infection, typically occurring during childhood, is asymptomatic in immunocompetent individuals and results in lifelong latency and persistent infection. However, among the severely immunocompromised, JCV may cause a fatal demyelinating disease, progressive multifocal leukoencephalopathy (PML). Virus-host interactions influencing persistence and pathogenicity are not well understood, although significant regulation of JCV activity is thought to occur at the level of transcription. Regulation of the JCV early and late promoters during the lytic cycle is a complex event that requires participation of both viral and cellular factors. We have used cDNA microarray technology to analyze global alterations in gene expression in JCV-permissive primary human fetal glial cells (PHFG). Expression of more than 400 cellular genes was altered, including many that influence cell proliferation, cell communication and interferon (IFN)-mediated host defense responses. Genes in the latter category included signal transducer and activator of transcription 1 (STAT1), interferon stimulating gene 56 (ISG56), myxovirus resistance 1 (MxA), 2'5'-oligoadenylate synthetase (OAS), and cig5. The expression of these genes was further confirmed in JCV-infected PHFG cells and the human glioblastoma cell line U87MG to ensure the specificity of JCV in inducing this strong antiviral response. Results obtained by real-time RT-PCR and Western blot analyses supported the microarray data and provide temporal information related to virus-induced changes in the IFN response pathway. Our data indicate that the induction of an antiviral response may be one of the cellular factors regulating/controlling JCV replication in immunocompetent hosts and therefore constraining the development of PML.
人类多瘤病毒JC(JCV)感染全球80%的人口。初次感染通常发生在儿童时期,在免疫功能正常的个体中无症状,并导致终身潜伏和持续感染。然而,在严重免疫功能低下的人群中,JCV可能会引发一种致命的脱髓鞘疾病——进行性多灶性白质脑病(PML)。尽管人们认为JCV活性的显著调节发生在转录水平,但影响病毒持续性和致病性的病毒与宿主之间的相互作用尚未得到充分了解。在裂解周期中,JCV早期和晚期启动子的调节是一个复杂的过程,需要病毒和细胞因子的共同参与。我们利用cDNA微阵列技术分析了JCV易感的原代人胎儿神经胶质细胞(PHFG)中基因表达的整体变化。400多个细胞基因的表达发生了改变,其中包括许多影响细胞增殖、细胞通讯和干扰素(IFN)介导的宿主防御反应的基因。后一类基因包括信号转导和转录激活因子1(STAT1)、干扰素刺激基因56(ISG56)、抗黏液病毒1(MxA)、2',5'-寡腺苷酸合成酶(OAS)和cig5。这些基因的表达在JCV感染的PHFG细胞和人胶质母细胞瘤细胞系U87MG中得到进一步证实,以确保JCV诱导这种强烈抗病毒反应的特异性。实时RT-PCR和蛋白质印迹分析获得的结果支持了微阵列数据,并提供了与病毒诱导的IFN反应途径变化相关的时间信息。我们的数据表明,诱导抗病毒反应可能是免疫功能正常宿主中调节/控制JCV复制的细胞因子之一,因此限制了PML的发展。